Recombinant Human Growth Hormone Improves Treatment of Patients With Cystic Fibrosis

Tweet

Recombinant human growth hormone (rhGH) improves growth in patients with growth hormone deficiency or idiopathic short stature.

This meta-analysis suggests that rhGH improved almost all intermediate measures of pulmonary function, height, and weight in patients with CF. Improvements in bone mineral content are also promising.

However, with the exception of hospitalizations, the benefits on final health outcomes cannot be directly determined at this time

References:

Recombinant Human Growth Hormone in the Treatment of Patients With Cystic Fibrosis. PEDIATRICS Vol. 126 No. 5 November 2010, pp. e1211-e1226 (doi:10.1542/peds.2010-2007).